A1 Refereed original research article in a scientific journal
Trends and results of oesophageal cancer surgery in Finland between 2004 and 2014
Authors: Olli Helminen, Eero Sihvo, Jarmo Gunn, Jussi O T Sipilä, Päivi Rautava, Ville Kytö
Publication year: 2020
Journal: European Journal of Cardio-Thoracic Surgery
Journal name in source: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Journal acronym: Eur J Cardiothorac Surg
Volume: 57
Issue: 1
First page : 107
Last page: 113
ISSN: 1010-7940
eISSN: 1873-734X
DOI: https://doi.org/10.1093/ejcts/ezz189
OBJECTIVES
Few population-based studies reporting trends in oesophageal cancer surgery exist. The aim of this study was to assess the incidence of oesophageal cancer, changes in resection rates, patient demographics and short- and long-term outcomes of oesophagectomy at the population level in Finland.
METHODSAll Finnish patients diagnosed with cancer of the oesophagus or gastrooesophageal junction between 1 January 2004 and 31 December 2014 identified from the nationwide registries were included. The follow-up ended on 31 December 2016. For evaluation of changes in demographics and treatment, data were divided into 2 periods: 2004–2009 and 2010–2014. For comparison of short-and long-term outcomes, adjustments for age, sex, comorbidity, tumour stage and histology were used.
RESULTSThe number of diagnosed oesophageal cancers was 4266. Of these, 740 underwent oesophagectomy. Resection rate increased from 15.2% in 2004–2009 to 19.6% in 2010–2014. The median number of oesophagectomies in Finnish hospitals increased from 1.9 to 3.7 per hospital per year. At the same time, minimally invasive surgery became more common (6.3% vs 35.1%, P < 0.0001) and a trend for increase in neoadjuvant treatment was observed (46.8% vs 53.8%, P = 0.0582). The rate of type III anastomosis leaks and conduit necroses was 5.1% without differences in time periods. Three-year [52.4% vs 61.6%, adjusted hazard ratio (HR) 0.75, 95% confidence interval (CI) 0.59–0.95] and 5-year survival (42.1% vs 56.5%, adjusted HR 0.70, 95% CI 0.57–0.87) improved.
CONCLUSIONSThis nationwide population-based study demonstrates an increase in resection rate, use of neoadjuvant treatment and minimally invasive surgery together with an improvement in long-term outcome after oesophageal cancer surgery.